Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To clarify the usefulness of molecular biomarkers for distinguishing invasive carcinoma
derived from intraductal papillary mucinous neoplasms (IPMNs [Inv-IPMN]) from concomitant
pancreatic ductal adenocarcinoma (PDAC).
[1
]
From the Departments of *Surgery and Oncology, †Anatomic Pathology, and ‡Clinical
Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.